BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 18207438)

  • 1. High oxygen environment during pregnancy rescues sickle cell anemia mice from prenatal death.
    Ye L; Chang JC; Lu R; Kan YW
    Blood Cells Mol Dis; 2008; 41(1):67-72. PubMed ID: 18207438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A transgenic mouse model of sickle cell disorder.
    Greaves DR; Fraser P; Vidal MA; Hedges MJ; Ropers D; Luzzatto L; Grosveld F
    Nature; 1990 Jan; 343(6254):183-5. PubMed ID: 2296310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse models of sickle cell disease.
    Beuzard Y
    Transfus Clin Biol; 2008; 15(1-2):7-11. PubMed ID: 18502677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-beta s-ribozyme reduces beta s mRNA levels in transgenic mice: potential application to the gene therapy of sickle cell anemia.
    Alami R; Gilman JG; Feng YQ; Marmorato A; Rochlin I; Suzuka SM; Fabry ME; Nagel RL; Bouhassira EE
    Blood Cells Mol Dis; 1999 Apr; 25(2):110-9. PubMed ID: 10389593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of sickle cell disease in transgenic mouse models by gene therapy.
    Pawliuk R; Westerman KA; Fabry ME; Payen E; Tighe R; Bouhassira EE; Acharya SA; Ellis J; London IM; Eaves CJ; Humphries RK; Beuzard Y; Nagel RL; Leboulch P
    Science; 2001 Dec; 294(5550):2368-71. PubMed ID: 11743206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic correction of sickle cell disease: insights using transgenic mouse models.
    Blouin MJ; Beauchemin H; Wright A; De Paepe M; Sorette M; Bleau AM; Nakamoto B; Ou CN; Stamatoyannopoulos G; Trudel M
    Nat Med; 2000 Feb; 6(2):177-82. PubMed ID: 10655106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A human embryonic hemoglobin inhibits Hb S polymerization in vitro and restores a normal phenotype to mouse models of sickle cell disease.
    He Z; Russell JE
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10635-40. PubMed ID: 12124399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
    Rodgers GP
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):2-7. PubMed ID: 9317195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major erythrocyte membrane protein genes in EKLF-deficient mice.
    Nilson DG; Sabatino DE; Bodine DM; Gallagher PG
    Exp Hematol; 2006 Jun; 34(6):705-12. PubMed ID: 16728274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of DNA fragments associated with the sickle-globin gene.
    Feldenzer J; Mears JG; Burns AL; Natta C; Bank A
    J Clin Invest; 1979 Sep; 64(3):751-5. PubMed ID: 468989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A humanized mouse model for a common beta0-thalassemia mutation.
    Jamsai D; Zaibak F; Khongnium W; Vadolas J; Voullaire L; Fowler KJ; Gazeas S; Fucharoen S; Williamson R; Ioannou PA
    Genomics; 2005 Apr; 85(4):453-61. PubMed ID: 15780748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential binding of beta s globin chains associated with stroma in sickle cell disorders.
    Bank A; Mears G; Weiss R; O'Donnell JV; Natta C
    J Clin Invest; 1974 Oct; 54(4):805-9. PubMed ID: 4430714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences.
    Fabry ME; Nagel RL; Pachnis A; Suzuka SM; Costantini F
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12150-4. PubMed ID: 1465454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of a sickle cell trait mouse model: human alpha(beta)(S) transgenes with one mouse beta-globin allele.
    Noguchi CT; Gladwin M; Diwan B; Merciris P; Smith R; Yu X; Buzard G; Fitzhugh A; Keefer LK; Schechter AN; Mohandas N
    Blood Cells Mol Dis; 2001; 27(6):971-7. PubMed ID: 11831863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia.
    Fabry ME; Costantini F; Pachnis A; Suzuka SM; Bank N; Aynedjian HS; Factor SM; Nagel RL
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12155-9. PubMed ID: 1465455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-bound hemoglobin in the erythrocytes of sickle cell anemia.
    Sears DA; Luthra MG
    J Lab Clin Med; 1983 Nov; 102(5):694-8. PubMed ID: 6631167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia.
    Sadelain M
    Curr Opin Hematol; 2006 May; 13(3):142-8. PubMed ID: 16567956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of alpha-globin genotype on the pathophysiology of sickle cell disease.
    Ballas SK
    Pediatr Pathol Mol Med; 2001; 20(2):107-21. PubMed ID: 12673836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Plasmodium falciparum growth in sickle cells in low oxygen environment and candle-jar.
    Orjih AU
    Acta Trop; 2005 Apr; 94(1):25-34. PubMed ID: 15777703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A recombinant human hemoglobin with anti-sickling properties greater than fetal hemoglobin.
    Levasseur DN; Ryan TM; Reilly MP; McCune SL; Asakura T; Townes TM
    J Biol Chem; 2004 Jun; 279(26):27518-24. PubMed ID: 15084588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.